Residue-Level Characterization of Antibody Binding Epitopes Using Carbene Chemical Footprinting

Jason M Hogan1, Peter S Lee1, Susan C Wong1

  • 1Discovery Biotherapeutics, Bristol Myers Squibb, 700 Bay Road, Redwood City, California 94063, United States.

Analytical Chemistry
|February 15, 2023
PubMed
Summary

Carbene chemical footprinting precisely maps antibody binding sites, accelerating therapeutic antibody discovery. This mass spectrometry technique identifies single-residue epitopes, enhancing drug development and understanding.